Ridgewood Investments LLC Organon & Co. Transaction History

Ridgewood Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$10.95 - $17.32 $229,709 - $363,338	-20,978 Reduced 59.8%	14,100 $203,000
Q3 2023 Oct 20, 2023	SELL	$16.59 - $23.77 $43,482 - $62,301	-2,621 Reduced 6.95%	35,078 $608,000
Q2 2023 Aug 07, 2023	BUY	$19.27 - $24.63 $27,729 - $35,442	1,439 Added 3.97%	37,699 $784,000
Q1 2023 Apr 25, 2023	BUY	$21.42 - $32.08 $22,897 - $34,293	1,069 Added 3.04%	36,260 $852,000
Q4 2022 Jan 19, 2023	BUY	$23.31 - $28.61 $92,074 - $113,009	3,950 Added 12.64%	35,191 $0
Q3 2022 Oct 13, 2022	BUY	$23.4 - $34.25 $84,076 - $123,060	3,593 Added 13.0%	31,241 $731,000
Q2 2022 Jul 19, 2022	BUY	$31.66 - $38.9 $875,335 - $1.08 Million	27,648 New	27,648 $933,000
Q1 2022 Apr 11, 2022	SELL	$30.45 - $39.36 $673,432 - $870,485	-22,116 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $81,766 - $105,894	2,852 Added 14.8%	22,116 $673,000
Q3 2021 Oct 20, 2021	BUY	$28.63 - $35.64 $84,630 - $105,351	2,956 Added 18.13%	19,264 $632,000
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $463,962 - $619,704	16,308 New	16,308 $493,000

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Ridgewood Investments LLC with notifications on news.